Progressive Rash,Oral Lesions,and History of Antibiotic Use in a 17-Year-Old Boy

Abstract

Get full access to this article

View all access options for this article.

References

Nirken

High

Roujeau

. Stevens–Johnson syndrome and toxic epidermal necrolysis: clinical manifestations; pathogenesis; and diagnosis. http://www.uptodate.com/contents/stevens-johnson-syndrome-and-toxic-epidermal-necrolysis-pathogenesis-clinical-manifestations-and-diagnosis. Accessed April 19, 2014.

Chovel-Sella

Ben Tov

Lahav

. Incidence of rash after amoxicillin treatment in children with infectious mononucleosis. Pediatrics. 2013;131:e1424-e1427.

Odom

. Andrew’s Diseases of the Skin. 9th ed. Philadelphia, PA: WB Saunders; 2000:136-138.

Powers

Carter-Beard

. Visual diagnosis: rash, eye pain, lesions in an adolescent. Pediatr Rev. 2010;31(12):e86-e90.

Roujeau

Kelly

Naldi

. Medication use and the risk of Stevens–Johnson syndrome or toxic epidermal necrolysis. N Engl J Med. 1995;333:1600-1608.

Tay

Huff

Weston

. Mycoplasma pneumoniae infection is associated with Stevens–Johnson syndrome, not erythema multiforme (von Hebra). J Am Acad Dermatol. 1996;35:757-760.

Khalili

Bahna

. Pathogenesis and recent therapeutic trends in Stevens-Johnson syndrome and toxic epidermal necrolysis. Ann Allergy Asthma Immunol. 2006;97:272-281.

Garcia-Doval

LeCleach

Bocquet

Otero

Roujeau

. Toxic epidermal necrolysis and Stevens–Johnson syndrome: does early withdrawal of causative drugs decrease the risk of death? Arch Dermatol. 2000;136:323-327.

Ghislain

Roujeau

. Treatment of severe drug reactions: Stevens–Johnson syndrome, toxic epidermal necrolysis and hypersensitivity syndrome. Dermatol Online J. 2002;8(1):5.

10.

Halebian

Corder

Madden

Finklestein

Shires

. Improved bum center survival of patients with toxic epidermal necrolysis managed without corticosteroids. Ann Surg. 1986;204:503-512.

11.

Bachot

Revuz

Roujeau

. Intravenous immunoglobulin treatment for Stevens–Johnson syndrome and toxic epidermal necrolysis: a prospective noncomparative study showing no benefit on mortality or progression. Arch Dermatol. 2003;139:33-36.

12.

Schneck

Fagot

Sekula

Sassolas

Roujeau

Mockenhaupt

. Effects of treatments on the mortality of Stevens–Johnson syndrome and toxic epidermal necrolysis: a retrospective study on patients included in the prospective EuroSCAR study. J Am Acad Dermatol. 2008;58:33-40.

13.

Prins

Vittorio

Padilla

. Effect of high-dose intravenous immunoglobulin therapy in Stevens–Johnson syndrome: a retrospective, multicenter study. Dermatology. 2003;207:96-99.